302 related articles for article (PubMed ID: 32009044)
1. [Dependence and Cytotoxicity of Components of Cannabis].
Funada M; Tomiyama KI
Yakugaku Zasshi; 2020; 140(2):205-214. PubMed ID: 32009044
[TBL] [Abstract][Full Text] [Related]
2. Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence.
Cooper ZD; Haney M
Int Rev Psychiatry; 2009 Apr; 21(2):104-12. PubMed ID: 19367504
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the role of CB
Li X; Hempel BJ; Yang HJ; Han X; Bi GH; Gardner EL; Xi ZX
Eur Neuropsychopharmacol; 2021 Feb; 43():38-51. PubMed ID: 33334652
[TBL] [Abstract][Full Text] [Related]
4. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?
Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL
Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death.
Tomiyama K; Funada M
Toxicol Appl Pharmacol; 2014 Jan; 274(1):17-23. PubMed ID: 24211273
[TBL] [Abstract][Full Text] [Related]
6. CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ
Han X; He Y; Bi GH; Zhang HY; Song R; Liu QR; Egan JM; Gardner EL; Li J; Xi ZX
Sci Rep; 2017 Sep; 7(1):12315. PubMed ID: 28951549
[TBL] [Abstract][Full Text] [Related]
7. Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal
Linciano P; Citti C; Luongo L; Belardo C; Maione S; Vandelli MA; Forni F; Gigli G; Laganà A; Montone CM; Cannazza G
J Nat Prod; 2020 Jan; 83(1):88-98. PubMed ID: 31891265
[TBL] [Abstract][Full Text] [Related]
8. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
van Amsterdam J; Brunt T; van den Brink W
J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor.
Fischedick J; Van Der Kooy F; Verpoorte R
Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):201-7. PubMed ID: 20118579
[TBL] [Abstract][Full Text] [Related]
10. Δ(9)-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats.
Gatch MB; Forster MJ
Psychopharmacology (Berl); 2016 May; 233(10):1901-10. PubMed ID: 26875756
[TBL] [Abstract][Full Text] [Related]
11. Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.
Cooper ZD; Haney M
Addict Biol; 2008 Jun; 13(2):188-95. PubMed ID: 18279497
[TBL] [Abstract][Full Text] [Related]
12. Synthetic cannabinoids found in "spice" products alter body temperature and cardiovascular parameters in conscious male rats.
Schindler CW; Gramling BR; Justinova Z; Thorndike EB; Baumann MH
Drug Alcohol Depend; 2017 Oct; 179():387-394. PubMed ID: 28846955
[TBL] [Abstract][Full Text] [Related]
13. Synthetic cannabinoids JWH-018, JWH-122, UR-144 and the phytocannabinoid THC activate apoptosis in placental cells.
Almada M; Alves P; Fonseca BM; Carvalho F; Queirós CR; Gaspar H; Amaral C; Teixeira NA; Correia-da-Silva G
Toxicol Lett; 2020 Feb; 319():129-137. PubMed ID: 31730886
[TBL] [Abstract][Full Text] [Related]
14. Self-administration of inhaled delta-9-tetrahydrocannabinol and synthetic cannabinoids in non-human primates.
Cooper ZD; Evans SM; Foltin RW
Exp Clin Psychopharmacol; 2021 Apr; 29(2):137-146. PubMed ID: 34043398
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Rice J; Cameron M
Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
[TBL] [Abstract][Full Text] [Related]
16. Self-administration of edible Δ
Smoker MP; Mackie K; Lapish CC; Boehm SL
Drug Alcohol Depend; 2019 Jun; 199():106-115. PubMed ID: 31029878
[TBL] [Abstract][Full Text] [Related]
17. "Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans.
Gunderson EW; Haughey HM; Ait-Daoud N; Joshi AS; Hart CL
Am J Addict; 2012; 21(4):320-6. PubMed ID: 22691010
[TBL] [Abstract][Full Text] [Related]
18. Receptor mechanisms underlying the CNS effects of cannabinoids: CB
Hempel B; Xi ZX
Adv Pharmacol; 2022; 93():275-333. PubMed ID: 35341569
[TBL] [Abstract][Full Text] [Related]
19. [Drug Dependence and Toxicity of Law-Evading Drugs: Their Mechanisms Explored from Basic Research].
Funada M
Brain Nerve; 2016 Oct; 68(10):1149-1158. PubMed ID: 27703102
[TBL] [Abstract][Full Text] [Related]
20. Selected cannabis terpenes synergize with THC to produce increased CB1 receptor activation.
Raz N; Eyal AM; Zeitouni DB; Hen-Shoval D; Davidson EM; Danieli A; Tauber M; Ben-Chaim Y
Biochem Pharmacol; 2023 Jun; 212():115548. PubMed ID: 37084981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
